First Russian intradermal implant obtained registration

Print 20 June 2018
GMP News

The first Russian intradermal implant has successfully passed the state registration. This product has been developed over the past three years with the support of the Russian Ministry of Industry and Trade as part of the state policy of import substitution.

The original formulation of the product was elaborated by a research company that is resident of Skolkovo Foundation. A unique germanium-organic compound developed under the innovative technology patented in Russia, USA, Europe, Canada, Japan, China, South Korea, and Australia was used as a structure stabilizer. The results of studies showed that, for a number of quality and efficiency indicators, the developed fillers based on hyaluronic acid are not only equal but even superior to many foreign analogs.

Another important factor is affordable competitive price of the final product. First serial lot of the product is being prepared for the launch in the Russian market that is expected to occur at the end of this August. The immediate plans of the manufacturer include launching to the Russian market several more innovative cosmetic and medicinal products that have no analogs in the world.

Source

Return